Ionis Pharmaceuticals (NASDAQ:IONS) Coverage Initiated at Redburn Atlantic
Research analysts at Redburn Atlantic began coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) in a report released on Monday, Marketbeat Ratings reports. The brokerage set a “neutral” rating and a $39.00 price target on the stock. Redburn Atlantic’s price objective would suggest a potential upside of 43.07% from the stock’s current […]
Research analysts at Redburn Atlantic began coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) in a report released on Monday, Marketbeat Ratings reports. The brokerage set a “neutral” rating and a $39.00 price target on the stock. Redburn Atlantic’s price objective would suggest a potential upside of 43.07% from the stock’s current […]
